VRS
CRSP icon

Virginia Retirement Systems’s CRISPR Therapeutics CRSP Stock Holding History

Virginia Retirement Systems’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.04M Buy
19,880
+5,550
+39% +$332K 0.01% 568
2025
Q3 		$929K Sell
14,330
-7,900
-36% -$454K 0.01% 614
2025
Q2 		$1.08M Sell
22,230
-2,700
-11% -$104K 0.01% 553
2025
Q1 		$848K Buy
+24,930
New +$1.06M 0.01% 599
2023
Q3 		$971K Buy
21,400
+9,600
+81% +$496K 0.01% 516
2023
Q2 		$662K Buy
11,800
+4,400
+59% +$250K 0.01% 652
2023
Q1 		$335K Buy
+7,400
New +$359K ﹤0.01% 849
2022
Q4 		– Sell
-13,600
Closed -$889K – 1147
2022
Q3 		$889K Buy
+13,600
New +$986K 0.01% 611
2022
Q1 		$1.14M Buy
18,200
+1,100
+6% +$69.1K 0.01% 590
2021
Q4 		$1.3K Buy
17,100
+1,800
+12% +$157K 0.01% 562
2021
Q3 		$1.71M Buy
15,300
+8,900
+139% +$1.12M 0.02% 467
2021
Q2 		$1.04M Sell
6,400
-600
-9% -$73K 0.01% 638
2021
Q1 		$853K Buy
7,000
+2,500
+56% +$377K 0.01% 710
2020
Q4 		$689K Sell
4,500
-10,600
-70% -$1.25M 0.01% 738
2020
Q3 		$1.26M Buy
15,100
+800
+6% +$71K 0.01% 481
2020
Q2 		$1.05M Buy
14,300
+400
+3% +$23.4K 0.01% 540
2020
Q1 		$589K Buy
+13,900
New +$718K 0.01% 735

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GP
GSK plc London $599M AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Virginia Retirement Systems's CRSP Position: Q4 2025 in Review

Virginia Retirement Systems increased its CRISPR Therapeutics (CRSP) stake by 39% in Q4 2025, buying an estimated $332K and bringing the position to 19,880 shares worth $1.04M. The position accounts for 0.01% of the portfolio, ranked #568.

Virginia Retirement Systems first reported a position in CRSP in Q1 2020 and has held it in 17 quarters since. The position peaked at $1.71M in Q3 2021. 479 funds tracked by Wall St. Rank hold CRSP as of Q4 2025.

  • Virginia Retirement Systems held 19,880 shares of CRISPR Therapeutics worth $1.04M as of Q4 2025.
  • Virginia Retirement Systems bought 5,550 CRISPR Therapeutics shares in Q4 2025, an estimated $332K.
  • CRISPR Therapeutics made up 0.01% of Virginia Retirement Systems's portfolio in Q4 2025, its #568 holding.
  • Virginia Retirement Systems first reported a position in CRISPR Therapeutics in Q1 2020 and has held it in 17 quarters since.
  • Virginia Retirement Systems's CRISPR Therapeutics position peaked at $1.71M in Q3 2021.
  • 479 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q4 2025.

Based on Virginia Retirement Systems's 13F filing for Q4 2025, filed 4 Feb 2026.